The Janus face of parathyroid hormone in renal osteodystrophy.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 41864665.
- Also identified by DOI 10.1016/j.kint.2026.01.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This editorial comment discusses novel insights into renal osteodystrophy from a parallel publication, highlighting that uremia per se independently impairs bone cell viability and induces skeletal parathyroid hormone resistance. Using multimodal bone analyses, Wagner et al. show that parathyroid hormone exerts compartment-specific effects: protective for trabecular osteocytes yet detrimental to cortical integrity via increased porosity and by bone fibrosis and increased resorption. These findings redefine optimal parathyroid hormone targets and emphasize addressing uremic toxicity to reduce fracture risk in chronic kidney disease.
Medical subject headings
- Chronic Kidney Disease-Mineral and Bone Disorder
- Parathyroid Hormone
- Uremia
- Bone and Bones
- Renal Insufficiency, Chronic